HOME >> MEDICINE >> NEWS
Many Gay Men Infected With HIV Are Opting To Delay Treatment, Despite,,Availability Of Drugs

Geneva, Switzerland -- HIV-infected gay men in the United States who want drug therapy for HIV are generally able to get it, but not all of them are immediately jumping on the drug bandwagon, according to a study by University of California San Francisco AIDS researchers.

Many men may be cautiously waiting to see how their disease progresses before committing to a lifetime of a difficult drug regimen, said Ron Stall, PhD, MPH, a research scientist with the UCSF Center for AIDS Prevention Studies and the UCSF AIDS Research Institute.

Stall presented the study findings here today (July 1) at the 12th World AIDS Conference.

Research results showed 56 percent of 500 randomly selected HIV-infected men surveyed in New York, Los Angeles, Chicago, and San Francisco--the cities with the largest gay communities in the United States--were using multiple-drug therapy consisting of a protease inhibitor in combination with other anti-retroviral drugs. The study found no major differences in the rates among the cities.

"What I found surprising was the inability to detect differences based on income or ethnicity," Stall said. "All were in the range of 50 to 60 percent taking combination therapy. This tells me that even low-income gay men can get drugs if they push the system."

One significant finding was the link between individuals using combination therapy and those with advanced HIV infection. The study showed that CD4 T cell counts--which are lower in the later stages of infection because the virus enters these immune cells and kills them--were a very good predictor of who would be on combination therapy, according to Stall. Findings showed 80 percent of persons with CD4 T cell counts of less than 200 were following combination therapy, while only 40 percent of those with counts of more than 500 were on therapy.

Men with counts above 500 may feel like they are doing fine, Stall concluded. "Many are quite aware what their options are and they have de
'"/>

Contact: Mitzi Baker
mabaker@itsa.ucsf.edu
(415) 476-2557
University of California - San Francisco
1-Jul-1998


Page: 1 2

Related medicine news :

1. Study Shows Efavirenz Promising In Treating Pediatric HIV Infection: Leads To Approval Of New Drug For Testing HIV-Infected Children
2. TB Prophylaxis Unnecessary In HIV-Infected People With Anergy, Study Suggests
3. Delayed hospice care can increase depression among survivors after death of a loved one
4. Delays in test result reviewing common
5. Delay in transfer to the ICU increases risk of death
6. Delayed care may affect prostate cancer deaths in blacks
7. Delays in heart attack care erode the difference between two emergency therapies
8. Delaying chemotherapy could be best option for certain type of non-hodgkin lymphoma
9. Delay in diagnosis for AS patients can lead to permanent spinal damage
10. Delaying disability in elderly
11. Wake Up To Stroke -- Night Strokes Linked To Long Delays In Care

Post Your Comments:
(Date:5/19/2013)... 19, 2013 According to a ... and Forecast (2013 – 2018): By Applications (Healthcare ... Technology (CCD, CMOS, Contact IS, Infrared, X-Ray) And ... sensor market was $8.00 billion in 2012 and ... at an estimated CAGR of 3.84% from 2013 ...
(Date:5/19/2013)... May 19, 2013 The report “Feed ... Trends & Forecasts up to 2017” published by MarketsandMarkets, ... with analysis and forecasting of the global volume and ... the driving and restraining factors for the global market ... and challenges. The market is segmented and revenue is ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 Americans live ... to the newest American Veterinary Medical Association (AVMA) U.S. ... American dog owners consider their dog a member of ... had said as much five years earlier. , According ... value of the national income dedicated to pets has ...
(Date:5/19/2013)... 2013 The Fat Loss Code program developed ... that help people get in shape, and gain a ... The program also is a natural fat loss system that ... author of this fat loss diet program claimed that The ... help people keep body fat off long-term. After Shawn Stevenson ...
(Date:5/19/2013)... 19, 2013 Agora Health Limited developed by ... guides on how to increase memory power naturally ... method that helps people re-new their entire health from the ... depression caused by a fatigued mind. In addition, the program ... for a lifetime. The author claimed that this program can ...
Breaking Medicine News(10 mins):Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 2Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 3Health News:Feed Additives Market to Reach $19.5 Billion by 2017 at a CAGR of 3.8% - New Report by MarketandMarkets 2Health News:Feed Additives Market to Reach $19.5 Billion by 2017 at a CAGR of 3.8% - New Report by MarketandMarkets 3Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 2Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 3Health News:Weight Loss Secrets | How “The Fat Loss Code” Helps People Gain A Healthy Life And Get In Shape - Health Review 2Health News:How To Increase Memory Power | How “Agora Health Limited” Helps People Improve Their Memory Naturally And Effectively – Health Review 2
(Date:5/17/2013)... , May 17, 2013 ... economics and outcomes research also   to   be ... SHPG ), the global specialty biopharmaceutical company, ... poster presentations at the American Psychiatric Association (APA) 166th ... May 18-22. The data being presented represent Shire,s ongoing ...
(Date:5/17/2013)... 17, 2013 Fuse Science, Inc. (OTCQB: DROP), ( ... is developing new, patent-pending technologies poised to redefine how consumers ... will hold a business update teleconference and webcast for shareholders ... 2013 at 4:30 PM ET. Fuse Science, ... the call and will be joined by Rubin ...
(Date:5/17/2013)... , May 17, 2013 ... developer of oral drug delivery systems, announced today that ... cleared the Company,s Investigational New Drug application(IND) for ORMD-0801, ... pleased to have the FDA clearance to proceed," stated ... "The upcoming trial is a major milestone for Oramed ...
Breaking Medicine Technology:Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 2Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 3Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 4Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 5Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 6Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 7Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 8Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 9Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 10Fuse Science, Inc. to Hold Business Update Webcast and Teleconference on May 22nd 2Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 2Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 3
Cached News: